speb/financial-data huggingface dataset:
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Operating Income: 233114000.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 3577047000.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 1550000.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 658041000.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 222816000.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 2285179000.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 75811000.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 49166000.00
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.22
INSECTICID.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 3343933000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — +Operating Expense: 4185450000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1100535000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — +Total Revenue: 19943348000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 3589205000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 5077444000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5077444000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 3853165000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3853165000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1832918000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1832918000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 14359000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 14359000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -231355000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -231355000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Amortization: 13893000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 13893000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 85318000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 85318000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 29354001.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 29121803.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Basic EPS: 48.38
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 4.77
INSECTICID.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 612826000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1231751000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1231751000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -372890000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 50414000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 50414000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 290978000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 290978000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 559270000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 559270000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 666264000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 666264000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -59196000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 350215000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 350215000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 208975000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 208975000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -788627000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -31634000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -152362000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Change In Payable: 910541000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Change In Prepaid Assets: -3072000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -940866000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -979526000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -53556000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Common Stock: 290978000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 290978000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 10845941000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10845941000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: -618802000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1603864000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1603864000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 13797876000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2275625000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Current Assets: 14250679000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 14250679000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 23954000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 23954000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Current Debt: 761499000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 761499000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 785453000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 785453000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 7775000000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 7775000000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 48382000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 48382000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Depreciation: 277641000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 291534000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 291534000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 71704000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 277641000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 71704000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 29354001.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 29121803.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Diluted EPS: 48.38
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 4.77
INSECTICID.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1420186000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 138911000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 562000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 562000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 2217000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — EBIT: 1976424000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — EBIT: 241642000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — EBITDA: 2267958000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — EBITDA: 313346000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — End Cash Position: 559270000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -610922000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 4950171000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 4950171000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 561679000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 24291000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -1909000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 167529000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 136193000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 136193000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 4084520000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 4084520000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 6139171000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6139171000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Gross Profit: 6145472000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1313580000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 7775000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 7775000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 5914000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Interest Expense: 48730000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 21409000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 48730000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 21409000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Interest Income: 23551000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 23551000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -69855000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 23551000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Inventory: 8862454000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 8862454000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 11842164000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 11842164000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -377203000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 29915000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 29915000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 85318000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 85318000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 115237000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 115237000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 70859000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 494267000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 494267000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 26460000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 26460000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 234724000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 234724000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 261184000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 261184000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 70859000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -133112000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 115237000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 115237000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 55026000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 55026000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2758703000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 2758703000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: -618802000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Net Debt: 436953000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 436953000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -29015000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Net Income: 1420186000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Net Income: 138911000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1420186000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 138911000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1420186000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 138911000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1420186000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 138911000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1420186000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 138911000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1927694000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1420186000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 138911000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Net Interest Income: -45094000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -21409000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -56268000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 158972000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -62253000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -45094000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -21409000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Net PPE: 4306253000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 4306253000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -346703000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 221225000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 10709748000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 10709748000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 44308000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 44308000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 55026000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 55026000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 57833000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 57833000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 2301462000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 313346000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Normalized Income: 1444869332.39
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 138911000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 934569000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Operating Income: 1960022000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Operating Income: 213045000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Operating Revenue: 19943348000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 3589205000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 29097837.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 29097837.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 785486000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 785486000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1306438000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1306438000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 10554960000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 10554960000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 136193000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 136193000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 249422000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 249422000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 45094000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 28000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 28000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 10551000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 28555000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1730205000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 742484000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Payable: 416559000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 416559000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Properties: 50586000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 50586000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 74973000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 74973000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 106994000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 106994000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Other Special Charges: -1909000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Payables: 5582571000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Payables: 5582571000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 48382000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 48382000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 785486000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 785486000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Pretax Income: 1927694000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 220233000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 77248000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -80485000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -372890000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 2875512000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 2875512000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 13797876000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2275625000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 291534000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 71704000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 6613000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 6613000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -133112000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Repurchase Of Capital Stock: -618802000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Research And Development: 99903000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 562000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 562000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 10464447000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 10464447000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 24217000.00
INSECTICID.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 26187000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 554627000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 722156000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Share Issued: 29097837.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 29097837.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Special Income Charges: -6931000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 10845941000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10845941000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 10709748000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 10709748000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -8820667.61
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Tax Provision: 507508000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 81322000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.37
INSECTICID.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -418023000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Total Assets: 18981456000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 18981456000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 11080665000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 11080665000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1046637000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1046637000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 10845938000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 10845938000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Total Expenses: 17983326000.00
INSECTICID.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 3376160000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 8135518000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 8135518000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 4730777000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 4730777000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 360518000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 360518000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 19915000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 88006000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 88006000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -33504000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -33504000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Work In Process: 787349000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 787349000.00
INSECTICID.NS balance_sheet (annual, 2025-03-31) — Working Capital: 6475679000.00
INSECTICID.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 6475679000.00
INSECTICID.NS income_statement (annual, 2025-03-31) — Write Off: 2926000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1243782000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 6911331000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 29096345.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 19.97
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4894826000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 73128000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 73128000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 29096345.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 19.97
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 581054000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — EBIT: 811761000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — EBITDA: 884889000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 2016505000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 37226000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 37226000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Net Income: 581054000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 581054000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 581054000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 581054000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 581054000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 581054000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -37226000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -37226000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 884889000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 581054000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Operating Income: 772723000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 6911331000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 37057000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 755402000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 774535000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4894826000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 73128000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 193481000.00
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
INSECTICID.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 6138608000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1395710000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 6377009000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4203679000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 6426946000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 147230000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 29102659.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 20.31
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 74159000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 290978000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 270091000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 440947000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 290978000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 12031452000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 813668000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 4179820000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 14936151000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 27619000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 2174023000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2201642000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 7563755000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 71382000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 93299000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 93299000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 29102659.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 20.31
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 591075000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — EBIT: 830124000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — EBITDA: 923423000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 185730000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4437880000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 2197189000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 41553000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 41553000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 7441315000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 14421747000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 30984000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 147230000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 46540000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 216272000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 262812000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 120794000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 55322000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2120204000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Net Income: 591075000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 591075000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 591075000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 591075000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 591075000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 591075000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -41553000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -41553000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 4437880000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 11845722000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 54005000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 923423000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 591075000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Operating Income: 801479000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 6377009000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 29097837.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 623307000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 374719000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 11740474000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 185730000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 97489000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 25087000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 824675000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 3624212000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 3636000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 170856000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Payables: 4277471000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 788571000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 4179820000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 93299000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 29097837.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 12031452000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 11845722000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 197496000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 19967346000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 12247724000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2464454000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 12031452000.00
INSECTICID.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 5575530000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7935894000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5031195000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 372139000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 73792000.00
INSECTICID.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 7372396000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1068686000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 3849162000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 29133889.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 3.60
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2600704000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 94123000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 94123000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 29133889.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 3.60
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 104882000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — EBIT: 189844000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — EBITDA: 283967000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1248458000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 46818000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 46818000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Net Income: 104882000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 104882000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 104882000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 104882000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 104882000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 104882000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -46818000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -46818000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 283967000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 104882000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Operating Income: 179772000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 3849162000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 7625000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 610006000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 143026000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2600704000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 94123000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 38144000.00
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
INSECTICID.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 3669390000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4588350000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1127113000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — +Total Revenue: 21366182000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 4262596000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 4392632000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4392632000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 4869720000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4869720000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -2111854000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -2111854000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 14359000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 14359000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -276030000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -276030000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Amortization: 15565000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 15565000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 137295000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 137295000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 29097837.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 29129104.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Basic EPS: 47.91
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 4.02
INSECTICID.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 559270000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1535529000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1535529000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -945917000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 127637000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 127637000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 290978000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 290978000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 872264000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 872264000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 917915000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 917915000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -58196000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 520083000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 520083000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 352181000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 352181000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 1060327000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -18927000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -34008000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Change In Payable: -747668000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: -5048000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -1012870000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -801422000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 312994000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Common Stock: 290978000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 290978000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 12204121000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 12204121000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Common Stock Payments: 0.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1364413000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1364413000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 14745876000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2973933000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Current Assets: 14477824000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 14477824000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 37597000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 37597000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1255044000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1255044000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1292641000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1292641000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 7403969000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 7403969000.00
INSECTICID.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 41871000.00
INSECTICID.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 41871000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Depreciation: 339394000.00
INSECTICID.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 354959000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 354959000.00
INSECTICID.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 94409000.00
INSECTICID.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 339394000.00